Halpin, David M.G.Dickens, Andrew PSkinner, DerekMurray, Ruth BSingh, MukeshHickman, KatherineCarter, VictoriaCouper, AmyEvans, AlexanderPullen, RachelMenon, ShrutiMorris, TamsinMuellerova, HanaBafadhel, MonaChalmers, JamesDevereux, GrahamGibson, MartinHurst, John R.Jones, RupertKostikas, KonstantinosQuint, JenniferSingh, Davevan Melle, MarijeWilkinson, Tom M.A.Price, David2023-04-242023-04-242023-06-01Halpin, D M G, Dickens, A P, Skinner, D, Murray, R B, Singh, M, Hickman, K, Carter, V, Couper, A, Evans, A, Pullen, R, Menon, S, Morris, T, Muellerova, H, Bafadhel, M, Chalmers, J, Devereux, G, Gibson, M, Hurst, J R, Jones, R, Kostikas, K, Quint, J, Singh, D, van Melle, M, Wilkinson, T M A & Price, D 2023, 'Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST Quality Standards : an observational longitudinal study', The Lancet Regional Health - Europe, vol. 29, 100619. https://doi.org/10.1016/j.lanepe.2023.1006192666-7762https://hdl.handle.net/2164/20540Funding: This study is conducted by the Observational & Pragmatic Research International Ltd and was co-funded by Optimum Patient Care and AstraZeneca. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution. Acknowledgments We acknowledge Jonathan Marshall, Clementine Nordon, Mehul Patel, Michael Pollack, and Yang Xu, of AstraZeneca, for their contributions to the development and review of the protocol, and Kathleen Heil, of AstraZeneca, for project management support. We would also like to acknowledge Ms Shilpa Suresh (MSc) and Ms Andrea Lim (BSc) of the Observational and Pragmatic Research Institute (OPRI), Singapore, for editorial and formatting assistance which supported the development of this publication.14853197engCOPDDiagnosisSpirometryExacerbationsTreatmentPulmonary rehabilitationR MedicineRJournal article10.1016/j.lanepe.2023.10061929